Skip to main content

Table 1 Dynamic changes in alpha-fetoprotein (AFP) level of the patient with advanced hepatocellular carcinoma before and after sorafenib treatment

From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib

Detection time Detection method AFP (ng/ml) Assessment
2010.10.25 Chemiluminescence 51750.00 Normal range, 0–20 ng/ml
2010.11.29 Chemiluminescence 21668.00 Decrease by >50% in week 5
2011.02.16 Chemiluminescence 54.33 Close to normal in week 15
2011.04.14 Chemiluminescence <10 Normal in week 23
2011.05.18–13.11.12 Chemiluminescence <10 Normal for >30 months